Targeting Tumor-derived Sphingosine Kinase 2 Unleashes Antitumor Immunity and Improves Survival of Mice with Group 3 Medulloblastoma
Sampurna Chatterjee, Pragya Kumar, Ashwin Srinivasan Kumar, Pin‐Ji Lei, Meenal Datta, Yuhui Zhao, William W. Ho, Nilesh P. Talele, Patrik Andersson, Mark A. Duquette, Shuji Kitahara, Landry Blanc, Samantha J. Wong, Wilhelmus Josephus Kwanten, David H. Ebb, , Rakesh K. Jain
This study identifies SPHK2 as a therapeutic target in G3MB, showing that its inhibition restores anti-tumor immunity and improves survival in mouse models, with enhanced effects when combined with radiation.
bioRxiv · Aug 14, 2026 · PreprintCancer Biology